(PBH) Prestige Brand Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74112D1019

PBH: Pain Relievers, Skincare, Eye Care, Dental Care, Digestive Aid

Prestige Consumer Healthcare Inc. (NYSE:PBH) operates as a developer, manufacturer, and distributor of over-the-counter (OTC) health and personal care products. The company serves markets in North America, Australia, and other international regions, organizing its operations into two primary segments: North American OTC Healthcare and International OTC Healthcare. Its product portfolio includes a wide range of well-known brands that address common health and personal care needs.

The company’s offerings span multiple health categories, including pain relief, digestive health, and skincare. Under the BC and Goodys brands, it provides analgesic powders. The Boudreauxs Butt Paste brand specializes in diaper rash treatments and skin protectants. For throat and mouth pain, the Chloraseptic brand offers sprays and lozenges. Clear Eyes is its line of eye care products designed to alleviate redness and irritation. The Compound W brand focuses on at-home wart removal, while Debrox is dedicated to ear wax removal.

Additional products include dental care items under the DenTek brand, such as dental guards and floss picks. Dramamine is its solution for motion sickness. The Fleet brand covers enemas and laxatives, while Gaviscon is aimed at treating upset stomachs. Ludens provides cough drops, and Monistat addresses yeast infections in women. The Nix brand offers treatments for lice and parasites. Feminine care products are available under the Summers Eve brand, and TheraTears focuses on dry eye relief. The Fess brand offers nasal saline sprays and washes, and Hydralyte is its oral rehydration solution.

Distribution channels include mass merchandisers, drug stores, food retailers, dollar stores chains, convenience stores, and e-commerce platforms. This broad reach ensures accessibility for its products across various consumer segments. The company, formerly known as Prestige Brands Holdings, Inc., rebranded to Prestige Consumer Healthcare Inc. in August 2018, reflecting its focus on healthcare products. Founded in 1996, it is headquartered in Tarrytown, New York.

Financially, Prestige Consumer Healthcare Inc. has a market capitalization

Additional Sources for PBH Stock

PBH Stock Overview

Market Cap in USD 4,410m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC Sub-Industry Pharmaceuticals
IPO / Inception 2005-02-10

PBH Stock Ratings

Growth 5y 88.6%
Fundamental 52.9%
Dividend 0.30%
Rel. Strength Industry 10.6
Analysts 3.88/5
Fair Price Momentum 90.21 USD
Fair Price DCF 116.00 USD

PBH Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 1.0%

PBH Growth Ratios

Growth Correlation 3m 56%
Growth Correlation 12m 76.3%
Growth Correlation 5y 90.5%
CAGR 5y 22.27%
CAGR/Max DD 5y 0.86
Sharpe Ratio 12m 0.15
Alpha 4.80
Beta 0.33
Volatility 24.95%
Current Volume 262.5k
Average Volume 20d 359.5k
What is the price of PBH stocks?
As of March 14, 2025, the stock is trading at USD 82.83 with a total of 262,472 shares traded.
Over the past week, the price has changed by -4.89%, over one month by -3.33%, over three months by +0.64% and over the past year by +10.34%.
Is Prestige Brand Holdings a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Prestige Brand Holdings (NYSE:PBH) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.90 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PBH as of March 2025 is 90.21. This means that PBH is currently overvalued and has a potential downside of 8.91%.
Is PBH a buy, sell or hold?
Prestige Brand Holdings has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy PBH.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
What are the forecast for PBH stock price target?
According to ValueRays Forecast Model, PBH Prestige Brand Holdings will be worth about 97.6 in March 2026. The stock is currently trading at 82.83. This means that the stock has a potential upside of +17.88%.
Issuer Forecast Upside
Wallstreet Target Price 89.1 7.6%
Analysts Target Price 85.3 3%
ValueRay Target Price 97.6 17.9%